Novacyt Gets CE Marks for Winterplex, Escapeplex COVID-19 PCR Tests

October 5, 2021

Novacyt has received a CE mark for its Winterplex polymerase chain-reaction (PCR) test for diagnosis of COVID-19, respiratory syncytial virus (RSV) and some types of influenza.

The new version of its Winterplex test combines flu B, three-gene COVID-19, flu A and RSV assays in a single kit, and is designed for use in central laboratories with open PCR platforms.

The company has also earned a separate CE mark for its Escapeplex PCR test for identifying four COVID-19 variants.

Novacyt has been marketing Escapeplex as a research-use-only test since April. The new CE marked version is intended for clinical use.

View today's stories